Role of P2X7 receptor in Clostridium perfringens beta-toxin-mediated cellular injury

Biochimica et Biophysica Acta - General Subjects

Volumn 1850, Issue 11, 2015, Pages 2159-2167

  Nagahama, Masahiro ^a   Seike, Soshi ^a   Shirai, Hidenori ^a   Takagishi, Teruhisa ^a   Kobayashi, Keiko ^a   Takehara, Masaya ^a   Sakurai, Jun ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

C. perfringens beta toxin; Oligomer formation; P2X7 receptor; Pore forming toxin

Indexed keywords

ADENOSINE DIPHOSPHATE; BRILLIANT BLUE; CLOSTRIDIUM TOXIN; PHOSPHATE BUFFERED SALINE; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; BACTERIAL TOXIN; CALCIUM; COOMASSIE BRILLIANT BLUE; CPB PROTEIN, CLOSTRIDIUM PERFRINGENS; FUCHSINE; MEMBRANE PROTEIN; SECRETASE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL SURFACE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOTOXICITY; DOT HYBRIDIZATION; DRUG TARGETING; GENE SILENCING; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LETHALITY; LIPID RAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR BLOCKING; ANIMAL; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHYSIOLOGY;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BACTERIAL TOXINS; CALCIUM; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; RECEPTORS, PURINERGIC P2X7; RNA, SMALL INTERFERING; ROSANILINE DYES;

EID: 84940496772     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.08.011     Document Type: Article

References (42)

1. J.G. Songer Clostridial enteric diseases of domestic animals Clin. Microbiol. Rev. 9 1996 216 234
2. J. Sakurai, and M. Nagahama Clostridium perfringens beta-toxin: characterization and action Toxin Rev. 25 2006 89 108
3. M. Nagahama, S. Ochi, M. Oda, K. Miyamoto, M. Takehara, and K. Kobayashi Recent insights into Clostridium perfringens beta-toxin Toxins (Basel) 7 2015 396 406
4. J. Miclard, M. Jäggi, E. Sutter, M. Wyder, B. Grabscheid, and H. Posthaus Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets Vet. Microbiol. 137 2009 320 325
5. C. Gurtner, F. Popescu, M. Wyder, E. Sutter, F. Zeeh, J. Frey, C. von Schubert, and H. Posthaus Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells Infect. Immun. 78 2010 2966 2973
6. F. Popescu, M. Wyder, C. Gurtner, J. Frey, R.A. Cooke, A.R. Greenhill, and H. Posthaus Susceptibility of primary human endothelial cells to C. perfringens beta-toxin suggesting similar pathogenesis in human and porcine necrotizing enteritis Vet. Microbiol. 153 2011 173 177
7. M. Nagahama, A. Kihara, T. Miyawaki, M. Mukai, Y. Sakaguchi, S. Ochi, and J. Sakurai Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity Biochim. Biophys. Acta 1454 1999 97 105
8. M. Nagahama, S. Morimitsu, A. Kihara, M. Akita, K. Setsu, and J. Sakurai Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation Br. J. Pharmacol. 138 2003 23 30
9. M. Nagahama, A. Kihara, H. Kintoh, M. Oda, and J. Sakurai Involvement of tumor necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice Br. J. Pharmacol. 153 2008 1296 1302
10. S.E. Hunter, J.E. Brown, P.C. Oyston, J. Sakurai, and R.W. Titball Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus Infect. Immun. 61 1993 3958 3965
11. O. Shatursky, R. Bayles, M. Rogers, B.H. Jost, J.G. Songer, and R.K. Tweten Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers Infect. Immun. 68 2000 5546 5551
12. R.K. Tweten Clostridium perfringens beta-toxin and Clostridium septicum alpha-toxin: their mechanisms and possible role in pathogenesis Vet. Microbiol. 82 2001 1 9
13. M. Nagahama, S. Hayashi, S. Morimitsu, and J. Sakurai Biological activities and pore formation of Clostridium perfringens beta-toxin in HL 60 cells J. Biol. Chem. 278 2003 36934 36941
14. M. Nagahama, M. Shibutani, S. Seike, T. Takagishi, M. Oda, K. Kobayashi, and J. Sakurai The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin Infect. Immun. 81 2013 3703 3708
15. M. Skals, N.R. Jorgensen, J. Leipziger, and H.A. Praetorius Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis Proc. Natl. Acad. Sci. U. S. A. 106 2009 4030 4035
16. M. Skals, J. Leipziger, and H.A. Praetorius Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation Pflugers Arch. 462 2011 669 679
17. S.K. Fagerberg, M. Skals, J. Leipziger, and H.A. Praetorius P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells Toxins (Basel) 5 2013 472 487
18. J. Sakurai, and Y. Fujii Purification and characterization of Clostridium perfringens beta toxin Toxicon 25 1987 1301 1310
19. J. Sakurai, Y. Fujii, M. Matsuura, and K. Endo Pharmacological effect of beta toxin of Clostridium perfringens type C on rats Microbiol. Immunol. 25 1981 423 432
20. M. Nagahama, M. Umezaki, R. Tashiro, M. Oda, K. Kobayashi, M. Shibutani, T. Takagishi, K. Ishidoh, M. Fukuda, and J. Sakurai Intracellular trafficking of Clostridium perfringens iota-toxin b Infect. Immun. 80 2012 3410 3416
21. 7 receptors to distinct intracellular signaling pathways in rat submandibular gland J. Lipid Res. 47 2006 705 714
22. 7 receptor expression and localization in mouse lung alveolar epithelial cells FEBS J. 274 2007 3021 3033
23. F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J.M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O.R. Baricordi Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood 97 2001 587 600
24. R.A. North Molecular physiology of P2X receptors Physiol. Rev. 82 2002 1013 1067
25. M.P. Abbracchio, G. Burnstock, J.M. Boeynaems, E.A. Barnard, J.L. Boyer, C. Kennedy, G.E. Knight, M. Fumagalli, C. Gachet, K.A. Jacobson, and G.A. Weisman International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy Pharmacol. Rev. 58 2006 281 341
26. L. Erb, Z. Liao, C.I. Seye, and G.A. Weisman P2 receptors: intracellular signaling Pflugers Arch. 452 2006 552 562
27. G. Burnstock, and G.E. Knight Cellular distribution and functions of P2 receptor subtypes in different systems Int. Rev. Cytol. 240 2004 31 304
28. 7-transfected HEK293 cells Mol. Biol. Cell 14 2003 2655 2664
29. 7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells Am. J. Physiol. Cell Physiol. 285 2003 C286 299
30. B.J. Gu, W.Y. Zhang, L.J. Bendall, I.P. Chessell, G.N. Buell, and J.S. Wiley Expression of P2X7 purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X7 receptors Am. J. Physiol. Cell Physiol. 279 2000 C1189 1197
31. P.S. Munksgaard, T. Vorup-Jensen, J. Reinholdt, C.M. Söderström, K. Poulsen, J. Leipziger, H.A. Praetorius, and M. Skals Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes Cell. Microbiol. 14 2012 1904 1920
32. 6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion Eur. J. Immunol. 39 2009 2885 2894
33. G.A. Wilke, and J.B. Wardenburg Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury Proc. Natl. Acad. Sci. U. S. A. 107 2010 13473 13478
34. I. Inoshima, N. Inoshima, G.A. Wilke, M.E. Powers, K.M. Frank, Y. Wang, and J. Bubeck Wardenburg A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice Nat. Med. 17 2011 1310 1314
35. K. Reiss, and S. Bhakdi Pore-forming bacterial toxins and antimicrobial peptides as modulators of ADAM function Med. Microbiol. Immunol. 201 2012 419 426
36. G.R. Dubyak P2X7 receptor regulation of non-classical secretion from immune effector cells Cell. Microbiol. 14 2012 1697 1706
37. 7 receptor in infectious diseases PLoS Pathog. 7 2011 e1002212
38. J. Miclard, J. van Baarlen, M. Wyder, B. Grabscheid, and H. Posthaus Clostridium perfringens beta-toxin binding to vascular endothelial cells in a human case of enteritis necroticans J. Med. Microbiol. 58 2009 826 828
39. S. Sayeed, F.A. Uzal, D.J. Fisher, J. Saputo, J.E. Vidal, Y. Chen, P. Gupta, J.I. Rood, and B.A. McClane Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model Mol. Microbiol. 67 2008 15 30
40. J.E. Vidal, B.A. McClane, J. Saputo, J. Parker, and F.A. Uzal Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon Infect. Immun. 76 2008 4396 4404
41. J.A. Roberts, M.K. Lukewich, K.A. Sharkey, J.B. Furness, G.M. Mawe, and A.E. Lomax The roles of purinergic signaling during gastrointestinal inflammation Curr. Opin. Pharmacol. 12 2012 659 666
42. F.A. Uzal, and B.A. McClane Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections Vet. Microbiol. 153 2011 37 43